These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
945 related articles for article (PubMed ID: 16600680)
1. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680 [TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700 [TBL] [Abstract][Full Text] [Related]
4. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Mitchell HM; Hazell SL; Li YY; Hu PJ Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699 [TBL] [Abstract][Full Text] [Related]
7. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252 [TBL] [Abstract][Full Text] [Related]
9. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori CagA(+) infection in gastric cancer patients]. Ławniczak M; Starzyńska T Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of Western Blot method for the detection of antibodies to Helicobacter pylori antigens in patients with gastric carcinoma and cases with epigastric complaints]. Güdücüoğlu H; Berktaş M; Bozkurt H; Toka Ozer T; Bulut G; Oztürk O; Ilhan M Mikrobiyol Bul; 2010 Jan; 44(1):21-8. PubMed ID: 20455395 [TBL] [Abstract][Full Text] [Related]
12. [Helicobacter pylori genotypes and their association with host's immune response]. Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051 [TBL] [Abstract][Full Text] [Related]
13. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases]. Yang G; Hu F; Jia J Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori antibodies and gastric cancer: a gender-related difference. Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215 [TBL] [Abstract][Full Text] [Related]
16. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults. Kikuchi S; Crabtree JE; Forman D; Kurosawa M Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302 [TBL] [Abstract][Full Text] [Related]
17. Relationship between Helicobacter pylori CagA status and colorectal cancer. Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957 [TBL] [Abstract][Full Text] [Related]
18. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence. Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014 [TBL] [Abstract][Full Text] [Related]
19. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689 [TBL] [Abstract][Full Text] [Related]
20. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer. Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]